Jersey site
Celltrion Acquires Eli Lilly’s New Jersey Manufacturing Site for $330 Million
Celltrion; Eli Lilly; New Jersey site; acquisition; biopharmaceutical manufacturing; US tariffs; contract manufacturing; supply chain; biosimilars; investment